Literature DB >> 33599834

Investigation of brain damage mechanism in middle cerebral artery occlusion/reperfusion rats based on i-TRAQ quantitative proteomics.

Quantao Ma1, Chunguo Wang2, Min Wang3, Yaqi Li3, Pengfei Li3, Jingkang Wang3, Long Cheng3, Yongcheng An4, Hongyu Dai3, Yuhui Duan3, Ting Wang5, Baosheng Zhao6.   

Abstract

The objective of this study is to analyze the differential protein expression profile in cerebral cortex of rats with middle cerebral ischemia/reperfusion (MCAO/R), explore the brain damage mechanism of MCAO/R at protein level, and provide experimental foundation for searching specific marker proteins of MCAO/R. Rat model of MCAO/R was established by modified suture-occluded method, and the model was evaluated by the results of brain 2,3,5-triphenyltetrazolium chloride (TTC) and hematoxylin-eosin (HE) staining. Cerebral cortex of rats from sham-operated group (Sham) and MCAO/R groups was used for FASP enzymatic hydrolysis, i-TRAQ quantitative labeling, and reverse-phase liquid chromatography purification and separation. Orbitrap Q Exactive mass spectrometry was used for qualitative and quantitative analyses of total differential protein expression profiles. MCAO/R rats had obvious cerebral infarction lesions, and the relative surface area of cerebral infarction was significantly different compared with sham rats, suggesting that MCAO/R rat model was successfully prepared. There were 199 significant difference proteins (MCAO/R vs Sham, p < 0.05, |fold change|> 1.2), including 104 up-regulated proteins and 95 down-regulated proteins. Gene ontology (GO) enrichment analysis showed that the up-regulated proteins were mainly concentrated in the biological processes of positive regulation of NF-κB transcription and I-κB kinase-NF-κB, etc. Down-regulated proteins were mainly concentrated in long-term synaptic potentiation, cellular response to DNA damage stimulus, etc. KEGG pathway analysis showed that the pathway involved in differential proteins includes oxidative phosphorylation, metabolic pathway, and Ras signaling pathway. Network analysis of differential proteins showed that Alb, ndufb5, ndufs7, ApoB, Cdc42, Ndufa3, Igf1r, P4hb, Mbp, Gc, Nme1, Akt2, and other proteins may play an important role in regulating oxidative stress, apoptosis, and inflammatory response in MCAO/R. Quantitative proteomics based on i-TRAQ labeling reveals the effect of inflammation and apoptosis in brain damage mechanism of MCAO/R. Besides, this research provide some experimental foundation for search and determination of potential therapeutic targets of MCAO/R.

Entities:  

Keywords:  Brain damage mechanism; Differential proteins; MCAO/R; Potential therapeutic targets; Proteomics

Year:  2021        PMID: 33599834     DOI: 10.1007/s00221-021-06054-3

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  65 in total

1.  Binding of a C-terminal fragment (residues 369 to 435) of vitamin D-binding protein to actin.

Authors:  Stefan Buch; Dagmar Gremm; Albrecht Wegner; Hans Georg Mannherz
Journal:  Biol Chem       Date:  2002-10       Impact factor: 3.915

2.  Studies of the nature of the binding by albumin of platelet-activating factor released from cells.

Authors:  A J Ammit; C O'Neill
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

3.  Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.

Authors:  L Belayev; Y Liu; W Zhao; R Busto; M D Ginsberg
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

Review 4.  Post-stroke recovery: the role of activity-dependent release of brain-derived neurotrophic factor.

Authors:  Antonio Berretta; Yu-Chieh Tzeng; Andrew N Clarkson
Journal:  Expert Rev Neurother       Date:  2014-10-16       Impact factor: 4.618

5.  Mitochondrial oxidative stress and dysfunction induced by isoniazid: study on isolated rat liver and brain mitochondria.

Authors:  Morteza Ahadpour; Mohammad Reza Eskandari; Vida Mashayekhi; Kamaleddin Haj Mohammad Ebrahim Tehrani; Iman Jafarian; Parvaneh Naserzadeh; Mir-Jamal Hosseini
Journal:  Drug Chem Toxicol       Date:  2015-10-13       Impact factor: 3.356

6.  PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke.

Authors:  Laure Allard; Pierre R Burkhard; Pierre Lescuyer; Jennifer A Burgess; Nadia Walter; Denis F Hochstrasser; Jean-Charles Sanchez
Journal:  Clin Chem       Date:  2005-09-01       Impact factor: 8.327

Review 7.  Oxidative stress and its role in the pathogenesis of ischaemic stroke.

Authors:  C L Allen; U Bayraktutan
Journal:  Int J Stroke       Date:  2009-12       Impact factor: 5.266

8.  Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia.

Authors:  L Belayev; W Zhao; P M Pattany; R G Weaver; P W Huh; B Lin; R Busto; M D Ginsberg
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

9.  Increased expression of glutamate transporters in subcortical white matter after transient focal cerebral ischemia.

Authors:  Amaia M Arranz; Miroslav Gottlieb; Fernando Pérez-Cerdá; Carlos Matute
Journal:  Neurobiol Dis       Date:  2009-10-03       Impact factor: 5.996

10.  A p38MAPK/MK2 signaling pathway leading to redox stress, cell death and ischemia/reperfusion injury.

Authors:  Muhammad Imtiaz Ashraf; Matthias Ebner; Christoph Wallner; Martina Haller; Sana Khalid; Hubert Schwelberger; Katarzyna Koziel; Marion Enthammer; Martin Hermann; Stephan Sickinger; Afschin Soleiman; Christina Steger; Stephanie Vallant; Robert Sucher; Gerald Brandacher; Peter Santer; Duska Dragun; Jakob Troppmair
Journal:  Cell Commun Signal       Date:  2014-01-14       Impact factor: 5.712

View more
  1 in total

1.  Molecular mechanisms for the prevention and promoting the recovery from ischemic stroke by nutraceutical laminarin: A comparative transcriptomic approach.

Authors:  Jiefeng Luo; Dingzhi Chen; Biyun Qin; Deyan Kong
Journal:  Front Nutr       Date:  2022-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.